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Benzofurazans (Bf) represent an interesting class of 
organic compounds which is receiving increasing attention 
due to their use in different fields of chemistry.
1
 Compounds 
containing a benzofurazan (benzo[1,2-c][1,2,5]oxadiazole) 
skeleton have been widely used in the field of bioscience as 
fluorogenic and fluorescent reagents due to their chemical and 
physical properties such as the large Φf  values of the resultant 
derivatives, the high reactivity to analytes and the long 
excitation and emission wavelengths.
2 
 In particular, the 4,7-
disubstituted-benzofurazans found a broad application in 
bioanalytical chemistry
3-5 
due to their unique character 
regarding fluorescent properties.
6 
Experimental and 
theoretical works showed that the key factors in control of the 
fluorescence of 4,7-substituted benzofurazan dyes are the 
dipole moment across the benzene ring (from position 4 to 7) 
and the electron density found on the ring.
7 
 The commercially 
available 4-chloro-7-nitro-benzofurazan (NDBf-Cl) 1 
(Scheme 1) and, more in general, the 7-nitro-4-substituted 
benzofurazans (NDBf), are 10π electron heteroaromatic 
substrates which exhibit an extremely high electrophilic 
character
8
 and have been used as reactivity probes and as 
fluorescent labelling reagents in the study of a number of 
proteins.
9
 In addition, the NDBf derivatives also proved to 
possess several biological properties finding growing 
application in medicinal chemistry as 
antileukemic/antiapoptotic agents and monoamino oxidase 
inhibitors.
10-11. 
In the course of our studies on antiviral compounds
12-13
 we 
became interested in the synthesis of novel hits containing the 
NDBf nucleus. In particular we focused on the synthesis of 
NDBf derivatives  with general structure A (Scheme 1) 
containing an acylated cysteamine chain at C-4. Surprisingly 
we found that acylation of cysteamine derivative 2 led in the 
presence of Et3N to the formation of desired compound 3 
together with a fluorescent side product which, after NMR 
and MS analyses, revealed to be the S-acyl-derivative 4 
(Scheme 1). The formation of  this latter compound was 
assumed to be due to a S-N Smiles rearrangement of the 
cysteamine chain of 2 on the electrophilic benzofurazan core. 
The Smiles rearrangement is an intramolecular aromatic 
nucleophilic substitution of an appropriately placed 
nucleophile onto aromatic rings and it is usually catalysed by 
bases, acids  or heat.
16
 Few examples of O-O and S-O Smiles 
rearrangements on furazan, benzofurazan and benzofurazan-
N-oxide heterocycles have been described in literature and 
generally they occur in the presence of strong bases such 
NaOH or KOMe.
14
 However, to the best of our knowledge, no 
examples of S-N Smiles rearrangement on benzofurazans 
have been reported so far. 
Herein, we decided to investigate the influence of the 
Smiles rearrangement in the acylation of the 7-(2-
aminoethylthio)-4-nitrobenzofurazan. In particular, we 
demonstrated that the occurrence of the S-N Smiles 
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rearrangement on benzofurazan 2 is strictly dependent on 
the base and acylating agents used and that an appropriate 
setting up of the reaction conditions and a careful use of 
reagents could allow the selective S- or N- acylation of 2. 
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Scheme 1. Acylation of cysteamine derivative 2 
 
Cysteamine-NDBf 2 was prepared in almost quantitative yield 
through the reaction of cysteamine hydrochloride (1.1 eq) with 
NDBf-Cl 1 (1.0 eq) in refluxing ethanol and in the presence of a 
catalytic amount of KOAc (Scheme 1).
10-18 
As expected the more 
nucleophilic sulfur of cysteamine reacts with NDBf-Cl 1 faster 
than nitrogen atom leading selectively to C4-S derivative 2 while 
no traces of the C4-N regioisomer were observed.
 
We first 
decided to react 2 with different bases under mild conditions 
(DCM, 25 °C), in order to investigate its tendency to give the S-
N-Smile rearrangement (Scheme 2, Table 1). Treatment of NDBf 
2 with 1-2 eq of pyridine did not lead to the formation of the 
rearranged NDBf 5 also after several hours and starting 2 was 
completely recovered from the reaction mixture (entries 1-2). On 
the other hand, when 2 was treated with the more basic Et3N (1 
eq) partial conversion into 5 was observed by 
1
H-NMR (entry 3). 
Complete conversion was achieved by treatment of 2 with 2 eq of 
Et3N (entry 4). The 
1
H-NMR of compound 2 shows a typical H-5 
peak at 7.74 ppm while the H-5 proton of 4-N-analogue 5 falls at 
6.35 ppm. Similarly, treatment of  2 with MeONa (2 eq) led to 
complete conversion into 5 (entry 5), while in the presence of 
K2CO3 or KOH no rearrangement was observed even if higher 
amounts of bases were used (entries 6-7). According to literature 
data
14
 the Smiles rearrangement is supposed to proceed through a 
SNAr at ipso position with the formation of a  spirocyclic 
Meisenheimer complex intermediate 6 (Scheme 2). The first step 
of the reaction is the formation of the five-membered 
intermediate 6 due to the attack of the nucleophilic amine at the 
ipso position.  Deprotonation of 6 by a base leads to intermediate 
7 which is in turn converted into rearranged compound 5.
15
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Table 1. Base promoted Smile rearrangement on 2 
Entry Base Amount (eq.) 
Ratio (%)
a,b
 
2 5 
1 Pyr 1 100 N.D.
c
 
2 Pyr 2 100 N.D.
c
 
3 Et3N 1 70 30 
4 Et3N 2 N.D. 100 
5 MeONa 2 N.D. 100 
6 KOH 2 100 N.D.
c
 
7 K2CO3 2 100 N.D.
c
 
a
Ratios were determined by GC–MS and 1H-NMR analysis of 
the crude mixtures. 
b
Reactions were completed after 1h. 
c
Not 
detected. 
 
Since Et3N and MeONa favor the Smiles rearrangement of 2 
leading to the formation of 5, it was reasonable to assume that 
under  appropriate acylation conditions the formation of N- or S-
acyl derivatives could be selectively achieved. Hence, compound 
2 was reacted with different electron rich/poor acylating agents 
(namely thienyl, bezoyl and nicotinoyl chlorides) in the presence 
of different bases. Results are reported on Table 2. 
Thienyl (ThCl), benzoyl and nicotinoyl chorides (NicCl) were 
reacted with 2 in the presence of pyridine at r.t. leading to the 
slow formation of acyl derivatives 3a-c in several hours. On the 
other hand, the addition of DMAP accelerated dramatically the 
rate of the reaction leading to 3a and 3c in a few hours (5.5 and 3 
h respectively, entries 1 and 3). The formation of benzoyl 
derivative 3b proved to be faster and was accomplished in only 
30 minutes (entry 2). However, in all cases, only traces of the S-
acylated rearranged products 4 could be detected by 
1
H-NMR. A 
similar behavior of 2 was observed when the same acylation 
reactions were carried using KOH as a base (data not shown). 
Benzofurazan 2 was then reacted with ThCl in the presence of 
1.1 eq. of Et3N affording in 1 h a mixture of 3a/4a in a 1:1 ratio 
(entry 4). Compound 4a proved to be fluorescent as shown in 
Figure 1. Increasing the amount of Et3N to 1.5 eq led to the 
formation of 3a/4a in a 7:3 ratio in only 30 minutes, while the 
further increase of the base to 2 eq resulted into a drop of the 
isomeric ratio to 1:1 (entries 5-6). 
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Table 2. Formation of  S/N-acyl derivatives 3-4 through S-N Smiles rearrangement 
 
 
N
O
N
NO2
S
NH2
Ar
O
Cl
N
O
N
NO2
HN
S
N
O
N
NO2
S
N
H
Ar
O
Ar
O
2
3a-c
4a-c
Base
DCM, r.t.
3a-4a   Ar =
3b-4b   Ar =
3c-4c   Ar =
S
N
 
Entry Ar base base (eq.) Time (h) 
Ratio  (%)
a,b
 
3/4 
1 Thienyl Py 2 5.5 98:2
c
 
2 Ph Py 2 0.5 97:3
c
 
3 Nicotinoyl Py 2 3 100:0
c
 
4 Thienyl Et3N 1.1 1 55:45
c
 
5 Thienyl Et3N 1.5 0.5 70:30 
6 Thienyl Et3N 2 0.5 58:42 
7 Thienyl Et3N 2 1 55/45
d
 
8 Thienyl Et3N
 
 2 24
e
 92/8
e
 
9 Ph Et3N 1.1 0.5 40:60 
10 Ph Et3N
 
 2 0.3 27:73 
11 Nicotinoyl Et3N 1.1 4 100:0 
12 Nicotinoyl Et3N
 
 2 2 100:0 
13 Thienyl NaOMe 2 24 64:36 
14 Thienyl NaOMe 2 24 35:65
d
 
15 Ph NaOMe 2 24 40:60 
16 Nicotinoyl NaOMe 2 16 100:0 
aAll the reactions were monitored by TLC analysis and stopped after consumption of the 
cysteamine-NDBf 2. bRatios of products were determined by 1H-
NMR. cReaction was performed in the presence of a catalytic amount of DMAP. dStarting 
material 2 and base were premixed and the thiophene carbonyl chloride was added after 2 h. 
eThe reaction was left stirring for additional 24 h after the TLC showed the consumption of 2. 
 
These surprising results may be explained if a competition 
between the acylation step of 2 and the Et3N promoted Smiles 
rearrangement is assumed. Hence, it is reasonable to think that 
the base promotes the rearrangement of the cysteamine chain and 
in the meantime favors the N-acylation of 2 and the S-acylation 
of the forming 5.
16 
To confirm this assumption, compound 2 was 
treated with 2 eq of Et3N and the reaction mixture was stirred 2 h 
before adding ThCl. Formation of 4a as the only product was 
expected. Surprisingly, a 1:1 mixture of 3a and 4a was recovered 
from the reaction mixture (Entry 7). A base mediated 
equilibration between N- and S-acyl derivates 3a and 4a was then 
hypothesized and, in order to explain these results, we decided to 
treat compound 4a with 2 eq of Et3N. Quantitative conversion of 
4a into 3a  was observed by 
1
H-NMR within 24h proving that 
compound 4a is the kinetic product of the reaction and compound 
3a is the thermodynamic. According to Wieland and Bokelmann 
studies on cysteamine,
17
 a plausible mechanism for the 
conversion of 4a into 3a is reported in Scheme 3. On the basis of 
this result we can assume that the treatment of 2 with Et3N led to 
5 and addition of the ThCl after 2h led to the formation of kinetic 
product 4a. However, the base starts meanwhile to catalyze the 
conversion of 4a into 3a, thus affording a 1:1 mixture of the two 
products. As further corroboration, benzofurazan 2 was treated 
with ThCl and 2 eq of Et3N and the reaction was left to carry out 
for 24h (entry 8) leading to the formation of 3a as the major 
product in a 92:8 ratio. Interestingly, the treatment of 2 with 
BzCl in the presence Et3N led to the formation of S-benzoylated 
4b as the major product in a few minutes. In particular, when 2 
eq of base were used compounds 3b and 4b were obtained in a 
27:73 ratio (entry 10). As shown above, benzoylation proved to 
be faster than thienylation and nicotinoylation. The BzCl reacts 
fast with the forming rearranged compound 5 and thus leads the 
Tetrahedron 4 
reaction to completion before that equilibration of 4b into 3b 
could occur. Finally, NicCl reacts with 2 in the presence of Et3N 
leading to 3c as the only product (entries 11-12). We then 
investigated the acylation of 2 in the presence of MeONa. 
Treatment of 2 with ThCl led to a 3:2 mixture of 3a and 4a in 24 
h (entry 13). On the other hand, when compound 2 was premixed 
with MeONa and ThCl was added after 2 h, a 35:65 mixture of 
3a and 4a was obtained after 24 h (entry 14). Even in this case an 
equilibration of the kinetic into the thermodynamic product 
occurs. However, conversion of 4a into 3a catalyzed by MeONa 
occurred slower than in the presence of Et3N thus accounting the 
isolation of 4a as the major product. Finally, the reaction of 2 
with BzCl in the presence of MeONa led to  compounds 3b and 
4b in a 40:60 ratio, confirming the tendency of BzCl to favor the 
formation of S-acylated product. On the other hand, when NicCl 
was reacted with 2 only the N-nicotinoyl derivative 3c was 
isolated from the reaction mixture. Due to the higher 
electrophilicity of its chlorocarbonyl function, it is plausible that 
NicCl reacts with 2 before than the base could promote the Smile 
rearrangement, thus accounting for the selective formation of 3c. 
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Scheme 3. Equilibration of 4a into 3a 
 
In conclusion, the acylation reaction of  7-(2-aminoethylthio)-
4-nitrobenzofurazan 2 was thoroughly investigated.  The 
influence of the base and of the acyl donors on the outcome of 
reaction as well as the tendency of the substrate 2 to give the 
Smiles rearrangement has been highlighted. Smiles 
rearrangement on NDBfs bearing a cysteamine chain at C4 
occurs in the presence of Et3N and MeONa and lead to S- or N-
acylated NDBfs
18
 depending on the nature of the acylating group. 
In some cases, the unstable S-acylated benzofurazan derivatives 
can be obtained as the major reaction products. Finally, the S-
acyl derivatives 4a and 4b  are fluorescent and represent 
interesting scaffolds in the development of novel bioanalytical 
probes for the study of protein interactions. 
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